Beijing Winsunny Pharmaceutical CO.LTD (601089) — Cash Flow Reinvestment Rate
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Cash Flow Reinvestment Rate of 0.58x as of December 2024, reinvesting CN¥403.39 Million (capex CN¥391.52 Million plus investments CN¥11.87 Million) from operating cash flow of CN¥690.75 Million. Check how high is Beijing Winsunny Pharmaceutical CO.LTD's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beijing Winsunny Pharmaceutical CO.LTD Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. Explore Beijing Winsunny Pharmaceutical CO.LTD cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Year-by-year capital reinvestment analysis for Beijing Winsunny Pharmaceutical CO.LTD. For live market cap and broader valuation context, see Beijing Winsunny Pharmaceutical CO.LTD market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.58x | CN¥403.39 Million | CN¥690.75 Million | CN¥391.52 Million | ▼ -11.9% |
| 2023 | 0.66x | CN¥368.49 Million | CN¥555.90 Million | CN¥366.08 Million | ▲ +162.2% |
| 2022 | 0.25x | CN¥166.81 Million | CN¥659.76 Million | CN¥135.40 Million | ▼ -69.2% |
| 2021 | 0.82x | CN¥433.12 Million | CN¥528.02 Million | CN¥192.97 Million | ▼ -21.1% |
| 2020 | 1.04x | CN¥401.81 Million | CN¥386.65 Million | CN¥168.96 Million | — |